Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  WebMD Health Corp.    WBMD

Delayed Quote. Delayed  - 07/29 10:00:00 pm
61.01 USD   -0.13%
07/27 MEDSCAPE VACCIN : Health Care Professionals Report Increased Vaccine..
07/26 MEDSCAPE 2016 R : Despite Shrinking Gender Gap in Compensation, Medi..
07/11 WEBMD HEALTH : Announces Second Quarter Earnings Release Date And Co..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales515580636703770827
Operating income (EBITDA)84,3159193229262287
Operating profit (EBIT)57,796,3129161190214
Pre-Tax Profit (EBT)28,8-----
Net income15,142,178,188,5107127
P/E ratio12739,632,632,928,522,3
EPS ( $ )0,311,001,481,852,142,74
Dividend per Share ( $ )------
Yield------
Reference price ( $ )39.539.5548.361.0161.0161.01
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1272451622,28--
Finance----127268
Operating income (EBITDA)84,3159193229262287
Leverage
(Debt/EBITDA)
1,51x1,55x0,84x0,01x--
Capital Expenditure-23,248,431,829,130,5
Book Value Per Share (BVPS)4,25 $-----
Cash Flow per Share------
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 2 361 M$ -
Entreprise Value (EV) 2 363 M$ 2 233 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 32,9x 28,5x
Capitalization / Revenue 3,36x 3,06x
EV / Revenue 3,36x 2,90x
EV / EBITDA 10,3x 8,53x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,9% 24,6%
operating Leverage (Delta EBIT / Delta Sales) 2,38x 1,86x
Net Margin (Net Profit / Revenue) 12,6% 13,8%
ROA (Net Profit / Asset) 7,50% 9,10%
ROE (Net Profit / Equities) 45,9% 42,9%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   4,52% 3,78%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 1,68x 1,52x
Financial Leverage (Net Debt / EBITDA) 0,01x -0,49x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend